gene-silencing
-

Huntington's Disease Therapeutics Conference 2016 – day 2
7 min read
Strategies for getting rid of mutant huntingtin & clinical trial updates: day 2 of the HD therapeutics conference
-

New tool to measure outcomes in Huntington’s Disease clinical trials
6 min read
A better tool for HD trials! New research shows innovative way to measure mutant Huntingtin outside the brain
By Megan Krench -

2015 Huntington's Disease Therapeutics Conference: Day 2
8 min read
Day 2 of updates from the annual HD Therapeutics Conference in Palm Springs
-

Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
7 min read
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
By Dr Leora Fox -

'Buzzilia' from the Huntington's Disease World Congress: day 4
7 min read
#Buzzilia, day 4: Jeff and Ed's roundup of happenings from the closing day of the HD World Congress in Rio de Janeiro
-

Gene silencing drug safe in ALS patients… bring on Huntington's disease trials
7 min read
Gene silencing drug injected into spinal fluid in ALS patients proves safe. Good news for similar planned HD trials.



